Articles with public access mandates - Lena FribergLearn more
Not available anywhere: 5
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study
EI Nielsen, M Sandström, PH Honoré, U Ewald, LE Friberg
Clinical pharmacokinetics 48, 253-263, 2009
Mandates: US National Institutes of Health
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
A Thorsted, EI Nielsen, LE Friberg
International journal of antimicrobial agents 56 (3), 106059, 2020
Mandates: Swedish Research Council
Model-informed drug development in pulmonary delivery: semimechanistic pharmacokinetic–pharmacodynamic modeling for evaluation of treatments against chronic Pseudomonas …
T Sou, I Kukavica-Ibrulj, RC Levesque, LE Friberg, CAS Bergström
Molecular Pharmaceutics 17 (5), 1458-1469, 2020
Mandates: Swedish Research Council
Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia
A Gkoufa, T Sou, I Karaiskos, C Routsi, YW Lin, M Psichogiou, ...
International Journal of Antimicrobial Agents 59 (6), 106588, 2022
Mandates: Swedish Research Council for Environment, Agricultural Sciences and Spatial …
Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli
DD Khan, P Lagerbäck, C Malmberg, AN Kristoffersson, E Wistrand-Yuen, ...
International Journal of Antimicrobial Agents 51 (3), 399-406, 2018
Mandates: Swedish Research Council
Available somewhere: 38
From therapeutic drug monitoring to model‐informed precision dosing for antibiotics
SG Wicha, AG Märtson, EI Nielsen, BCP Koch, LE Friberg, JW Alffenaar, ...
Clinical Pharmacology & Therapeutics 109 (4), 928-941, 2021
Mandates: European Commission
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T Tängdén, V Ramos Martín, TW Felton, EI Nielsen, S Marchand, ...
Intensive care medicine 43, 1021-1032, 2017
Mandates: National Health and Medical Research Council, Australia
CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
AJM de Graan, L Elens, JA Sprowl, A Sparreboom, LE Friberg, ...
Clinical Cancer Research 19 (12), 3316-3324, 2013
Mandates: US National Institutes of Health, Dutch Cancer Society
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
AJM de Graan, CS Lancaster, A Obaidat, B Hagenbuch, L Elens, ...
Clinical Cancer Research 18 (16), 4433-4440, 2012
Mandates: US National Institutes of Health
Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety
D Ley, I Hansen-Pupp, A Niklasson, M Domellöf, LE Friberg, J Borg, ...
Pediatric research 73 (1), 68-74, 2013
Mandates: US National Institutes of Health, Swedish Research Council
A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants
C Löfqvist, A Niklasson, E Engström, LE Friberg, C Camacho-Hübner, ...
Pediatric research 65 (5), 574-579, 2009
Mandates: US National Institutes of Health
Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding (London 4–5 December 2014)
FT Musuamba, E Manolis, N Holford, SYA Cheung, LE Friberg, ...
CPT: pharmacometrics & systems pharmacology 6 (7), 418-429, 2017
Mandates: UK Medical Research Council
Semi-mechanistic pharmacokinetic–pharmacodynamic modelling of antibiotic drug combinations
MJE Brill, AN Kristoffersson, C Zhao, EI Nielsen, LE Friberg
Clinical Microbiology and Infection 24 (7), 697-706, 2018
Mandates: Swedish Research Council, European Commission
Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
AK Hamberg, LE Friberg, K Hanséus, BM Ekman-Joelsson, J Sunnegårdh, ...
European journal of clinical pharmacology 69, 1275-1283, 2013
Mandates: Swedish Research Council
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments
P Wistrand-Yuen, A Olsson, KP Skarp, LE Friberg, EI Nielsen, ...
Clinical Microbiology and Infection 26 (9), 1214-1221, 2020
Mandates: Swedish Research Council
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
AN Kristoffersson, V Rognås, MJE Brill, Y Dishon-Benattar, ...
Clinical Microbiology and Infection 26 (12), 1644-1650, 2020
Mandates: Swedish Research Council, European Commission
Efficacy of antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in automated time-lapse microscopy and static time-kill experiments
A Olsson, P Wistrand-Yuen, EI Nielsen, LE Friberg, L Sandegren, ...
Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 02111-19, 2020
Mandates: Swedish Research Council
Research priorities towards precision antibiotic therapy to improve patient care
ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard, RL Nation, ...
The Lancet Microbe 3 (10), e795-e802, 2022
Mandates: US National Institutes of Health
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platform
AJM de Graan, L Elens, M Smid, JW Martens, A Sparreboom, ...
Clinical Cancer Research 19 (18), 5210-5217, 2013
Mandates: Dutch Cancer Society
Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice
K Becker, V Aranzana-Climent, S Cao, A Nilsson, R Shariatgorji, ...
Clinical Microbiology and Infection 27 (9), 1315-1321, 2021
Mandates: Swedish Research Council
Publication and funding information is determined automatically by a computer program